Pneumothorax Treatment Market - Top Companies and Manufacturers

Top Featured Companies Dominating the Pneumothorax Treatment Landscape.

Medtronic
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Angiotech
BetaGlue
Teleflex Incorporated
Abbott
Smith’s Group plc
ATMOS MedizinTechnik GmbH & Co. KG
Sinapi Biomedical
Nobelpharma Co., Ltd
Vygon

Browse Key Market Insights with Data Illustration:

Pneumothorax Treatment Market Size | Forecast Report 2036

In the News

27 March 2024 - Medtronic plc (NYSE: MDT), a leading global supplier of medical technology, announced that the EvolutTM FX+ transcatheter aortic valve replacement (TAVR) system has received FDA approval in the US for the treatment of symptomatic severe aortic stenosis. The most recent Evolut FX+ TAVR system is intended to make coronary access easier while preserving the valve performance advantages of the previous Evolut TAVR platform.
31^st January 2024 - The world leader in science-based nutrition, Abbott (NYSE: ABT), has announced the introduction of its new PROTALITYTM brand. The first product in this range to cater to the increasing number of adults who want to lose weight without sacrificing healthy nutrition and muscle mass is the high-protein nutrition smoothie.

Frequently Asked Questions (FAQ)

The major factors driving the growth of the pneumothorax treatment market are the burgeoning incidence of pneumothorax in the global population, the rising smoking rate in the population, the increasing aging population, and the technological advancements in medicine, diagnosis, and management of pneumothorax infections.

The market size of pneumothorax treatment is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2024 â€“ 2036.

The major players in the market are Medtronic, Angiotech, BetaGlue, Teleflex Incorporated, Abbott, Smithâ€™s Group plc, ATMOS MedizinTechnik GmbH & Co. KG, Sinapi Biomedical, Nobelpharma Co., Ltd, Vygon, and others.

The hospital segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

Pneumothorax Treatment Market - Top Companies and Manufacturers

Top Featured Companies Dominating the Pneumothorax Treatment Landscape.

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the pneumothorax treatment market?

What would be the CAGR of the pneumothorax treatment market over the forecast period?

Who are the major players dominating the pneumothorax treatment market?

Which segment captures the largest market size in the type segment in the pneumothorax treatment market?

Which region will provide more business opportunities for the growth of the pneumothorax treatment market in the future?